Jacob Vincent Micallef is CSO at VOLITIONRX LTD (VNRX). They have made 7 open-market trades across 1 company since 2017, most recently 2026-03-17.
CIK 0001651671
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $298K since 2022, never a sale. Across 7 scored buys the stock is up 0.6% at ninety days, and 0.0 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VNRX | 572,179 | $104K |
Shares reported on the most recent Form 4, priced at the 2026-03-19 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 57% | 43% |
| Avg Move | +1.5% | -3.8% | +0.6% |
| Alpha | +2.8% | -0.1% | +0.0% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VNRX | BUY | 2025-05-19 | 2025-05-19 | $0.43 | $22K | +14.3% | +52.5% | +55.3% |
| VNRX | BUY | 2024-12-09 | 2024-12-10 | $0.57 | $25K | +15.0% | +10.9% | -1.3% |
| VNRX | BUY | 2023-08-29 | 2023-08-31 | $1.25 | $25K | +1.6% | -40.9% | -39.4% |
| VNRX | BUY | 2023-08-25 | 2023-08-28 | $1.24 | $25K | +4.9% | -40.5% | -37.0% |
| VNRX | BUY | 2022-12-16 | 2022-12-20 | $2.26 | $129K | -8.4% | +1.9% | -36.8% |
| VNRX | BUY | 2022-09-19 | 2022-09-20 | $1.70 | $22K | -20.5% | +4.1% | +32.7% |
| VNRX | BUY | 2022-08-26 | 2022-08-30 | $1.74 | $50K | +3.6% | -14.8% | +30.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.